Kewaunee Scientific Co. (NASDAQ:KEQU) VP Douglas J. Batdorff Sells 3,470 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU) VP Douglas J. Batdorff sold 3,470 shares of Kewaunee Scientific stock in a transaction that occurred on Monday, December 30th. The shares were sold at an average price of $65.50, for a total value of $227,285.00. Following the completion of the sale, the vice president now directly owns 5,000 shares in the company, valued at $327,500. This represents a 40.97 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Kewaunee Scientific Stock Down 1.1 %

Shares of NASDAQ KEQU opened at $62.00 on Friday. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average price of $45.63 and a 200 day moving average price of $44.05. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20. The stock has a market capitalization of $178.06 million, a price-to-earnings ratio of 9.83 and a beta of 0.80.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Institutional Investors Weigh In On Kewaunee Scientific

Institutional investors and hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. raised its holdings in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after purchasing an additional 900 shares during the last quarter. Barclays PLC acquired a new position in shares of Kewaunee Scientific during the 3rd quarter worth $121,000. Heron Bay Capital Management purchased a new stake in shares of Kewaunee Scientific in the 2nd quarter worth about $252,000. State Street Corp acquired a new stake in Kewaunee Scientific in the 3rd quarter valued at about $266,000. Finally, Ritholtz Wealth Management increased its holdings in Kewaunee Scientific by 24.6% during the 3rd quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock valued at $363,000 after acquiring an additional 2,156 shares in the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.